Search details
1.
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.
J Infect Dis
; 222(Suppl 1): S31-S40, 2020 07 09.
Article
in English
| MEDLINE | ID: mdl-32645160
2.
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis.
Ann Hepatol
; 17(6): 959-968, 2018 Oct 16.
Article
in English
| MEDLINE | ID: mdl-30600291
3.
Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1.
Infect Dis Ther
; 12(9): 2321-2335, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37751019
4.
Factors associated with self-reported adherence to daily oral pre-exposure prophylaxis among men who have sex with man and transgender women: PrEP Brasil study.
Int J STD AIDS
; 32(13): 1231-1241, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34311605
5.
Possible risk compensation, attitudes, and beliefs among Brazilian individuals potentially eligible for pre-exposure prophylaxis.
Int J STD AIDS
; 32(9): 806-815, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33615909
6.
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
Lancet HIV
; 5(3): e136-e145, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29467098
7.
Safety and immunovirologic outcomes with maraviroc combination regimens in patients with a history of past treatment failures and virologic resistance in Brazil: an open-label, multicenter phase 3b study.
AIDS Res Hum Retroviruses
; 29(9): 1203-10, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23731330
8.
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials.
AIDS
; 23(17): 2289-300, 2009 Nov 13.
Article
in English
| MEDLINE | ID: mdl-19710593
9.
Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil.
AIDS Res Hum Retroviruses
; 25(9): 861-7, 2009 Sep.
Article
in English
| MEDLINE | ID: mdl-19689190
10.
Safety and Immunovirologic Outcomes with Maraviroc Combination Regimens in Patients with a History of Past Treatment Failures and Virologic Resistance in Brazil: An Open-Label, Multicenter Phase 3b Study
AIDS res. hum. retroviruses
; 29(9): 1203-1210, Sept. 2013.
Article
in English
| SES-SP, SES SP - Instituto de Infectologia Emílio Ribas, SES-SP | ID: biblio-1059255
Results
1 -
10
de 10
1
Next >
>>